Q/C Technologies changes name and ticker symbol

Q/C Technologies, Inc., formerly TNF Pharmaceuticals, Inc., has formally changed its corporate name to Q/C Technologies, Inc. effective September 22, 2025.

Rhea-AI Filing Summary

Q/C Technologies, Inc., formerly TNF Pharmaceuticals, Inc., has formally changed its corporate name to Q/C Technologies, Inc. effective September 22, 2025. The company also changed its Nasdaq trading symbol from “TNFA” to “QCLS” before the market opened on September 25, 2025.

The name change was implemented through a Certificate of Amendment to the Certificate of Incorporation under Section 242 of the Delaware General Corporation Law, which did not require stockholder approval. The company states that the name change does not affect the rights of its security holders and that its CUSIP number remains the same. Press releases announcing the name change and ticker symbol change were issued on September 24 and 25, 2025.

8-K Event Classification

4 items: 1.01, 5.03, 7.01, 9.01

4 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TNFA change its corporate name to?

TNF Pharmaceuticals, Inc. changed its corporate name to Q/C Technologies, Inc. effective September 22, 2025, through a Certificate of Amendment to its Certificate of Incorporation.

When did TNFA change its Nasdaq ticker symbol from TNFA to QCLS?

Before the open of market trading on September 25, 2025, the company’s common stock stopped trading under the symbol “TNFA” and began trading on the Nasdaq Stock Market under “QCLS”.

Does the Q/C Technologies, Inc. name change affect shareholder rights?

The company states that the name change does not affect the rights of its security holders, meaning existing share rights remain the same.

Did TNFA need stockholder approval for the name change to Q/C Technologies, Inc.?

No. The name change was completed under Section 242 of the Delaware General Corporation Law, and the company states that stockholder approval was not required to complete the name change or approve the Certificate of Amendment.

Did the CUSIP number change when TNFA became Q/C Technologies, Inc.?

No. The company states there will be no change to its CUSIP in connection with the name change from TNF Pharmaceuticals, Inc. to Q/C Technologies, Inc.

How did Q/C Technologies, Inc. communicate the name and ticker changes?

The company issued a press release on September 24, 2025 announcing the corporate name change and a press release on September 25, 2025 announcing the ticker symbol change to QCLS.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/26/2025 - 05:10 PM EDT Learn about SEC filing dates

false --12-31 0001321834 0001321834 2025-09-22 2025-09-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 22, 2025

Q/C Technologies, Inc.

(Exact name of Registrant as specified in its charter)

Delaware		001-36268		22-2983783
(State or other jurisdiction of incorporation)		(Commission File No.)		(IRS Employer Identification No.)

1185 Avenue of the Americas, Suite 249
New York, NY		10036
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (856) 848-8698

TNF Pharmaceuticals, Inc.

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.001 per share		QCLS		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On September 22, 2025, the Company filed a Certificate of Amendment to Q/C Technologies, Inc. (the “Company”) Certificate of Incorporation (the “Certificate of Amendment”) to change the name of the Company from “TNF Pharmaceuticals, Inc.” to “Q/C Technologies, Inc.” effective as of September 22, 2025 (the “Name Change”). In addition, effective before the open of market trading on September 25, 2025, the Company’s common stock, par value $0.001 per share, ceased trading under the ticker symbol “TNFA” and began trading on the Nasdaq Stock Market under the ticker symbol “QCLS” (“Symbol Change”).

The Name Change does not affect the rights of the Company’s security holders. There will be no change to the Company’s CUSIP in connection with the Name Change.

Pursuant to Section 242 of the Delaware General Corporation Law, stockholder approval was not required to complete the Name Change or to approve or effect the Certificate of Amendment. The information set forth herein is qualified in its entirety by reference to the complete text of the Certificate of Amendment, a copy of which is filed with this report as Exhibit 3.1 and is incorporated by reference herein.

The matters described in Item 1.01 of this Current Report on Form 8-K related to the filing of the Certificate of Amendment is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On September 24, 2025, the Company issued a press release announcing the Name Change. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated by reference herein.

On September 25, 2025, the Company issued a press release announcing the Symbol Change. A copy of the press release is furnished hereto as Exhibit 99.2 and incorporated by reference herein.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
3.1		Certificate of Amendment of Certificate of Incorporation of Q/C Technologies, Inc.
99.1		Press Release, dated September 24, 2025.
99.2		Press Release, dated September 25, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Q/C TECHNOLOGIES, INC.
Date: September 26, 2025	By:	/s/ Joshua Silverman
	Name:	Joshua Silverman
	Title:	Executive Chairman